| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.095 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |